New EMA Advice for PML Prevention With Tysabri in MSNew EMA Advice for PML Prevention With Tysabri in MS
The European Medicines Agency has released new recommendations on PML prevention with natalizumab in multiple sclerosis. News Alerts
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
More News: Brain | European Medicines Agency (EMA) | Multiple Sclerosis | Neurology | Neurosurgery | Tysabri